Citations 1
A phase 1b/2 study combining MM-151 + nal-IRI + 5-FU + leucovorin in RAS-wildtype metastatic colorectal cancer (mCRC).
Chan, Emily , Harb, Wael A., Mody, Kabir , Jiang, Xiaoy, McClure, Ty, Valencia, A. Gonzalez, Fitzgerald, Jonathan B., Pipas, J. Marc , Nering, Rachel, Kearns, Jeffrey D. , Lewis, Lionel D.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: TPS3633-TPS3633
